You are viewing the site in preview mode

Skip to main content

Advertisement

Contact Michelle H. Nelson

From: Toll-like receptor agonist therapy can profoundly augment the antitumor activity of adoptively transferred CD8+ T cells without host preconditioning

Contact corresponding author